{"nct_id":"NCT00790933","title":"An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2009-05-22","start_date_type":"ACTUAL","primary_completion_date":"2017-10-31","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}